Sanofi

Sanofi

Sanofi

Overview
Date Founded

1973

Headquarters

54, rue La Boétie,Paris, Ile-de-France 75008

Type of Company

Public

Employees (Worldwide)

100K

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Hospitals & Patient Services
Medical Support Services

Company Description

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Contact Data
Trying to get in touch with decision makers at Sanofi? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Vice President & Chief Financial Officer

General Counsel

Chief Regulatory Officer

Executive Vice President, Chief People Officer

Chief Digital Officer

President, Merial North America

Head of IR North America & Asia

Executive Vice President, Global Head of Research & Development

Head of Human Resources

Paths to Sanofi
Potential Connections via
Relationship Science
You
Sanofi
Owners & Shareholders
Details Hidden

Dodge & Cox employs in-house, fundamental bottom-up research, a rigorous valuation discipline, and maintains a long-term investment horizon. Their investment decisions are made by a team of seasoned investment professionals. The firm’s approach stresses an evaluation of risk relative to opportunity and they seek investments that they believe are undervalued by the market.

Details Hidden

Amundi-IM invests through funds in all asset classes and main currencies. The firm believes that overall analysis of a company, including economic, social and environmental aspects, allows for better assessment of the risks and opportunities that may affect its long-term valuation.

Details Hidden

BIM offers both US and non-US equity investment strategies using a variety of investment styles including growth, value, core and enhanced equity, that are targeted to specific market-cap ranges, including small-, mid-, small/mid-, large- and all-cap, as well as geographic and industry sectors. The firm utilizes fixed-income strategies that are actively managed, model or index based. Actively managed fixed-income mandates generally employ an active investment style that emphasizes rotation among different types of debt on a relative value basis, specific security selection, quantitative analysis of each security and the portfolio as a whole and intensive credit analysis and review. Model-based institutional strategies typically invest across a broad spectrum of global fixed-income securities as well as currencies, futures and swaps. BIM employs a risk controlled, systematic process for portfolio construction and alpha generation. Alpha sources may include security selection, duration and yield curve positioning, industry rotation, asset allocation, and currency positioning. For institutional index strategies, BIM typically invests in accordance with the risk and return profile of the benchmark either by replicating the index, or utilizing security level or stratified sampling.

Recent Transactions
Details Hidden

Regeneron Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Baxter International, Inc. purchases Sanofi /Seprafilm Brand from Sanofi

Details Hidden

Sanofi purchases Synthorx, Inc.

Transaction Advisors
Legal Advisor

Advised onSanofi purchases Genzyme Corp.

Legal Advisor

Advised onSanofi purchases TargeGen, Inc.

Legal Advisor

Advised onSanofi purchases Genzyme Corp.

Legal Advisor

Advised onSanofi purchases Genzyme Corp.

Legal Advisor

Advised onSanofi purchases Bioverativ, Inc.

Legal Advisor

Advised onSanofi purchases Bioverativ, Inc.

Advisors & Consultants
Legal Advisor

Partner at Jones Day

Legal Advisor

Partner, Practice Leader Business & Tort Litigation at Jones Day

Legal Advisor

Partner at Jones Day

Clients

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies. The Prescription Pharmaceutical segment handles R&D, manufacturing, and sale of ethical drugs. It also provides the manufacture and sale of prescription pharmaceuticals; and businesses incidental or related thereto. The company was founded on October 3, 2011 and is headquartered in Tokyo, Japan.

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Key Stats and Financials As of 2019
Market Capitalization
$113B
Total Enterprise Value
$129B
Earnings Per Share
$2.33
Revenue
$36.1B
Total Debt
$25.9B
Total Equity
$59.1B
Enterprise Value Sales
3.57x
TEVNet Income
44.38x
Debt TEV
0.2x
Net Profit
$2.91B
Enterprise Value EBITDAOperating
13.14x
EBITDAMargin
27.19%
EBITDA
$9.82B
Three Year Compounded Annual Growth Rate Of Revenue
2.22%
Non-Profit Donations & Grants
Investments
Details Hidden

Dystar Holdings GmbH, part of Kiri Industries Ltd., is a German company. The firm functions as investment holding company.

Details Hidden

Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH.

Details Hidden

MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA.

Investors
Details Hidden

Founder at Icahn Enterprises LP

Suppliers
Publicis Groupe SA Hospitals & Patient Services | Paris, France

Publicis Groupe SA engages in the advertising industry. Its services include customer relationship management, direct marketing, sales promotion, events management, public relations, and corporate, multicultural and financial communications. The company was founded by Marcel Bleustein-Blanchet in 1926 and is headquartered in Paris, France.

Sodexo SA Other Business & Consulting Services | Issy-les-moulineaux, France

Sodexo SA engages in the provision of on-site services, benefits and rewards services, and personal and home care services. It offers integrated solutions which cover a variety of working and living environments and are available in client segments which include corporate, health care, education, defense, remote sites, justice services, seniors, and sports and leisure. Sodexo was founded by Pierre Bellon in 1966 and is headquartered in Issy-les-Moulineaux, France.

Neurones SA Internet Software & Services | Nanterre, France

Neurones SA engages in providing consulting and digital services. The company operates through the following segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure Services segment includes service desk, workstation outsourcing, server and application outsourcing in cloud, computing mode, IT security, IT operations, IT service management, and IT governance. The Application Services segment comprises of IT consulting for finance, SAP integration and outsourcing, IT training and working with change, and mobile applications. The Consulting segment provides management, digital marketing, and organization consulting. The company was founded by Luc de Chammard on December 5, 1984 and is headquartered in Nanterre, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sanofi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sanofi's profile does not indicate a business or promotional relationship of any kind between RelSci and Sanofi.